The Scotts Miracle-Gro (SMG) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
1 Feb, 2026Market Position, Brand Strength, and Innovation
Holds leading market shares in lawn, garden, and hydroponics with iconic brands like Miracle-Gro, Ortho, and Roundup, supported by scale, innovation, and retailer partnerships.
Expanded portfolio includes live goods, plant foods, new controls, and organic product lines, with increased marketing investment by 33% in peak season 2024.
Four R&D centers and high-return innovation investments drive category expansion and product launches.
Omnichannel presence and strong supply chain enable 95% on-time, in-full order fulfillment.
Committed to sustainability, associate development, and community engagement as part of GroMoreGood purpose.
Strategic Initiatives and Partnerships
Launched new organic lines, innovative campaigns with Martha Stewart, and Healthy Plus Lawn Food with dual benefits.
Deepening omnichannel and retailer relationships, including Amazon and major home centers, with 2,000+ seasonal associates for in-store presence.
Hawthorne Collective continues strategic cannabis investments, including a new stake in RIV Capital and Cansortium.
Retail partnerships and in-store associates drive category growth and consumer engagement.
Focused on disciplined capital allocation and declining leverage.
Financial Performance and Outlook
FY24 objectives include improving adjusted gross margin by at least 250 bps, generating $560M free cash flow, and advancing the Hawthorne strategy.
Updated FY24 guidance projects mid single-digit US Consumer net sales growth and total company adjusted EBITDA of $530M–$540M, a ~20% increase over FY23.
Inventory drawdown and a new AR Facility are expected to drive record free cash flow and enable over $350M in debt reduction by year-end.
Further margin expansion is anticipated in FY25, leveraging cost savings and favorable product mix.
Focused on returning to pre-pandemic EBITDA levels and maintaining dividends.
Latest events from The Scotts Miracle-Gro
- Hawthorne divestiture, margin gains, and share buyback support improved outlook.SMG
Q1 20264 Feb 2026 - Margin expansion, $150M supply chain savings, and 3% sales growth drive future value.SMG
Investor Day 20243 Feb 2026 - Q3 sales and margins surged, with net income and guidance both sharply improved.SMG
Q3 20242 Feb 2026 - All proposals passed and financial performance showed marked improvement.SMG
AGM 20262 Feb 2026 - 20% EBITDA growth, strong cash flow, and margin gains signal a robust turnaround.SMG
Q4 202416 Jan 2026 - Financial turnaround, board refreshment, and all proposals approved amid strong shareholder support.SMG
AGM 20259 Jan 2026 - Q1 sales and margin gains, U.S. Consumer up 11%, Hawthorne down 35%, outlook reaffirmed.SMG
Q1 20259 Jan 2026 - Strong margin and EPS growth in 2025, with further gains and buybacks expected in 2026.SMG
Q4 202529 Dec 2025 - Proxy covers director elections, pay, auditor ratification, and incentive plan amendment.SMG
Proxy Filing17 Dec 2025